APA

Seong D., Giralt S., Fischer H., Hayes K., Glassman A., Arlinghaus R., Xu J., Kantarjian H., Siciliano M. & Champlin R. (19970610). Usefulness of detection of minimal residual disease by 'hypermetaphase' fluorescent in situ hybridization after allogeneic BMT for chronic myelogenous leukemia. : Bone marrow transplantation.

Chicago

Seong D, Giralt S, Fischer H, Hayes K, Glassman A, Arlinghaus R, Xu J, Kantarjian H, Siciliano M and Champlin R. 19970610. Usefulness of detection of minimal residual disease by 'hypermetaphase' fluorescent in situ hybridization after allogeneic BMT for chronic myelogenous leukemia. : Bone marrow transplantation.

Harvard

Seong D., Giralt S., Fischer H., Hayes K., Glassman A., Arlinghaus R., Xu J., Kantarjian H., Siciliano M. and Champlin R. (19970610). Usefulness of detection of minimal residual disease by 'hypermetaphase' fluorescent in situ hybridization after allogeneic BMT for chronic myelogenous leukemia. : Bone marrow transplantation.

MLA

Seong D, Giralt S, Fischer H, Hayes K, Glassman A, Arlinghaus R, Xu J, Kantarjian H, Siciliano M and Champlin R. Usefulness of detection of minimal residual disease by 'hypermetaphase' fluorescent in situ hybridization after allogeneic BMT for chronic myelogenous leukemia. : Bone marrow transplantation. 19970610.